SARS-CoV-2 Drug Discovery: Targeting Viral Ion Channels
Image above: As well as the spike (S) protein which binds to human cells, there are other transmembrane proteins including the M class and the viroporin [...]
Charlotte’s Patch Clamp Journey So Far…
Metrion Scientist Dr Charlotte Hill explains how she first discovered the wonderful world of patch clamp electrophysiology and how she came to write the chapter "An Introduction [...]
Metrion and Grünenthal extend Ion Channel Research Agreement
Introduction Metrion Biosciences have had a longstanding relationship providing drug discovery research services to Grünenthal GmbH, a privately owned pharmaceutical company and global leader in pain management [...]
Metrion welcomes new Sales and Marketing Intern, Anna
Our new Sales and Marketing Intern Anna has written the following piece explaining how she first became interested in the sciences, her aspirations for the future and [...]
An Interview with Damian Bell by Artem Kondratskyi
Introducing Damian Bell: as a new member of the team at Metrion we are using an abridged version of an interview by Artem Kondratskyi for ionchannellibrary.com. A [...]
Improving Cardiac Safety Testing Protocols
Thank you to Dr John Ridley, Metrion Biosciences’ Business Manager for writing this article and to MedNous for publishing this work. This article [...]
Metrion is open for business
Metrion Biosciences is open to discuss your ion channel drug discovery and safety profiling requirements via info@metrionbiosciences.com. In response to the global COVID-19 outbreak, and to [...]
Metrion’s CEO reflects on participation in Goldman Sachs’ 10,000 Small Businesses UK
During the second half of 2019 Metrion’s CEO Andy Southan spent three months on the Goldman Sachs 10,000 Small Businesses programme. In this blog he reflects on the [...]